Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I.
about
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
P2860
Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oral cholinesterase inhibitor ...... ive systematic review, Part I.
@en
type
label
Oral cholinesterase inhibitor ...... ive systematic review, Part I.
@en
prefLabel
Oral cholinesterase inhibitor ...... ive systematic review, Part I.
@en
P1476
Oral cholinesterase inhibitor ...... ive systematic review, Part I.
@en
P2093
Sylvie Chouinard
P304
P356
10.1097/WNF.0B013E31802FA61A
P577
2007-05-01T00:00:00Z